TrialJournal of diabetes2020

Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.

Hyunju Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.